Pictures

A U.S. Army soldier from 3/1 AD Task Force Bulldog uses his night vision equipment before an early morning joint patrol with Afghan National Army (ANA) soldiers in a village in Kherwar district in Logar province, eastern Afghanistan, May 22, 2012. REUTERS/Danish Siddiqui

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Photo

Maxim Hot 100

The world's most beautiful women as chosen by Maxim readers.  Slideshow 

A cross is seen in Joplin, Missouri May 17, 2012. May 22 marks the one year anniversary of a deadly EF-5 tornado that ripped through the town, killing 161 people. The tornado damaged or destroyed about 7,500 homes and 500 other buildings, but the city is now well into a recovery mode that has spurred some segments of the local economy. REUTERS/Eric Thayer (UNITED STATES - Tags: DISASTER ENVIRONMENT RELIGION)

Joplin, one year after

May 22 marks the one year anniversary of a deadly tornado that ripped through Joplin, Missouri, killing 161 people.  Slideshow 

Glaxo says test on diabetes drug to support safety

LONDON | Wed Nov 14, 2007 12:49pm EST

LONDON (Reuters) - Drugmaker GlaxoSmithKline said further clinical trials would support for the safety of its diabetes drug Avandia, which U.S. regulators required on Wednesday to carry a black-box warning about the risk of heart attacks.

"GSK believes data from ongoing and future clinical trials will provide additional scientific support for both the benefit and safety of Avandia," it said in a statement.

"GSK has agreed to work with the FDA (Food and Drug Administration) to plan and carry out a clinical trial to further investigate the cardiovascular effects of Avandia."

(Reporting by Miyoung Kim; Editing by Quentin Bryar)
Health
Stocks
Regulatory News

Related Quotes and News

Company
Price
Related News
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.